Related Experiment Video
Updated: Jun 1, 2026

07:00
Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
Published on: May 7, 2019
Machine learning-based MRI radiomics identifies patients with degenerative cervical myelopathy and predicts baseline
Ramesh M Arnest1, Kevin M Koch2, Matthew D Budde1
1Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, USA.
Summary
Machine learning models using MRI radiomics can accurately classify Degenerative Cervical Myelopathy (DCM) and predict disease severity. This approach shows promise as an objective imaging biomarker for DCM screening.
Area of Science:
- Neuroimaging
- Radiology
- Machine Learning
Background:
- Degenerative Cervical Myelopathy (DCM) diagnosis relies on clinical evaluation and MRI, but early symptoms are subtle, leading to diagnostic uncertainty.
- Asymptomatic spinal cord compression in older adults complicates surgical intervention decisions.
- MRI-based radiomics offers quantitative texture analysis for microstructural spinal cord pathology, serving as a potential objective imaging biomarker.
Purpose of the Study:
- To assess machine learning models' accuracy in classifying DCM using MRI radiomics.
- To evaluate the models' ability to predict DCM disease severity.
- To determine the impact of imaging resolution on diagnostic performance.
Main Methods:
- Included 79 DCM patients and 51 healthy controls who underwent high-resolution 3D T2-weighted MRI.
- Automated spinal cord segmentation and radiomic feature extraction using Pyradiomics, followed by feature filtering.
- Machine learning algorithms (XGBoost, CatBoost, LightGBM, Random Forest, SVM) were optimized and evaluated using 5-fold cross-validation and an internal test set.
Main Results:
- Machine learning models accurately discriminated DCM from healthy controls (AUROC=0.93, accuracy=0.88).
- Radiomic features from high-resolution MRI outperformed standard MRI and conventional morphometry in diagnostic performance.
- Models effectively classified disease severity (macro-average AUROC=0.855), surpassing traditional imaging measures.
Conclusions:
- MRI-based radiomics combined with machine learning accurately predicts DCM status and disease severity.
- This approach shows potential as an objective imaging biomarker for DCM screening, independent of clinical data.
- External validation in larger, multi-vendor datasets is necessary for broader clinical application.
